Anterix Inc. (ATEX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 1,958 | 1,573 | 1,552 | 1,418 | 1,389 |
| Gross Profit | 1,958 | 1,573 | 1,552 | 1,418 | 1,389 |
| Operating Expenses | -17,877 | 10,634 | -59,123 | -21,063 | -8,007 |
| Operating Income | 19,835 | -9,061 | 60,675 | 22,481 | 9,396 |
| Other Income | 547 | 408 | 379 | 442 | 486 |
| Pre-tax Income | 20,382 | -8,653 | 61,054 | 22,923 | 9,882 |
| Income Tax | 1,862 | -2,052 | 7,518 | -2,257 | 674 |
| Net Income Continuous | 18,520 | -6,601 | 53,536 | 25,180 | 9,208 |
| Net Income | $18,520 | $-6,601 | $53,536 | $25,180 | $9,208 |
| EPS Basic Total Ops | 0.99 | -0.35 | 2.86 | 1.35 | 0.51 |
| EPS Basic Continuous Ops | 0.99 | -0.35 | 2.86 | 1.35 | 0.50 |
| EPS Diluted Total Ops | 0.97 | -0.35 | 2.86 | 1.35 | 0.51 |
| EPS Diluted Continuous Ops | 0.98 | -0.35 | 2.86 | 1.35 | 0.50 |
| EPS Diluted Before Non-Recurring Items | -0.41 | -0.35 | -0.14 | -0.48 | -0.36 |
| EBITDA(a) | $19,938 | $-8,957 | $60,808 | $22,605 | $9,472 |